Experimental autoimmune encephalomyelitis in Lewis rats: IFN-β acts as a tolerogenic adjuvant for induction of neuroantigen-dependent tolerance

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5331-5341

  Mannie, Mark D ^a   Abbott, Derek J ^a   Lori Blanchfield, J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; MYELIN BASIC PROTEIN; RECOMBINANT PROTEIN; VACCINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; LEWIS RAT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RAT; STRUCTURE ACTIVITY RELATION; VACCINATION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL LINE; GENETICS; GUINEA PIG; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GUINEA PIGS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; VACCINES, COMBINED;

EID: 66949115028     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803756     Document Type: Article

References (43)

1. Cassan, C., and R. S. Liblau. 2007. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients. J. Neurochem. 100: 883-892. (Pubitemid 46213915)
2. McFarland, H. F., and R. Martin. 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8: 913-919.
3. Hauser, S. L., and J. R. Oksenberg. 2006. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52: 61-76. (Pubitemid 44466355)
4. Javed, A., and A. T. Reder. 2006. Therapeutic role of β-interferons in multiple sclerosis. Pharmacol. Ther. 110: 35-56. (Pubitemid 43248725)
5. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6: 975-990.
6. Tourbah, A., and O. Lyon-Caen. 2007. Interferons in multiple sclerosis: ten years' experience. Biochimie 89: 899-902. (Pubitemid 47007705)
7. Gold, R., C. Linington, and H. Lassmann. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971. (Pubitemid 44289062)
8. Abreu, S. L. 1982. Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Commun. 11: 1-7. (Pubitemid 12073357)
9. Hertz, F., and R. Deghenghi. 1985. Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats. Agents Actions 16: 397-403. (Pubitemid 15040984)
10. Brod, S. A., M. Khan, R. H. Kerman, and M. Pappolla. 1995. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58: 61-69.
11. Brod, S. A., M. Scott, D. K. Burns, and J. T. Phillips. 1995. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons. J. Interferon Cytokine Res. 15: 115-122.
12. Yu, M., A. Nishiyama, B. D. Trapp, and V. K. Tuohy. 1996. Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64: 91-100. (Pubitemid 26053393)
13. Brod, S. A., and M. Khan. 1996. Oral administration of IFN-α is superior to subcutaneous administration of IFN-α in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J. Autoimmun. 9: 11-20. (Pubitemid 26141888)
14. Vriesendorp, F. J., R. E. Flynn, M. Khan, M. A. Pappolla, and S. A. Brod. 1996. Oral administration of type I interferon modulates the course of experimental allergic neuritis. Autoimmunity 24: 157-165.
15. Yasuda, C. L., A. Al-Sabbagh, E. C. Oliveira, B. M. Diaz-Bardales, A. A. Garcia, and L. M. Santos. 1999. Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion. Immunol Invest. 28: 115-126.
16. Zou, L. P., D. H. Ma, L. Wei, P. H. van der Meide, E. Mix, and J. Zhu. 1999. IFN-β suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue. J. Neurosci. Res. 56: 123-130.
17. Tuohy, V. K., M. Yu, L. Yin, P. M. Mathisen, J. M. Johnson, and J. A. Kawczak. 2000. Modulation of the IL-10/IL-12 cytokine circuit by interferon-β inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. J. Neuroimmunol. 111: 55-63.
18. Floris, S., S. R. Ruuls, A. Wierinckx, S. M. van der Pol, E. Dopp, P. H. van der Meide, C. D. Dijkstra, and H. E. De Vries. 2002. Interferon-β directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 127: 69-79. (Pubitemid 34603576)
19. Teige, I., A. Treschow, A. Teige, R. Mattsson, V. Navikas, T. Leanderson, R. Holmdahl, and S. Issazadeh-Navikas. 2003. IFN-β gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170: 4776-4784. (Pubitemid 36519987)
20. Teige, I., Y. Liu, and S. Issazadeh-Navikas. 2006. IFN-β inhibits T cell activation capacity of central nervous system APCs. J. Immunol. 177: 3542-3553. (Pubitemid 44359885)
21. Prinz, M., H. Schmidt, A. Mildner, K. P. Knobeloch, U. K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686.
22. Faria, A. M., and H. L. Weiner. 2006. Oral tolerance: therapeutic implications for autoimmune diseases. Clin. Dev. Immunol. 13: 143-157. (Pubitemid 44950033)
23. Fontoura, P., H. Garren, and L. Steinman. 2005. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides. Int. Rev. Immunol. 24: 415-446. (Pubitemid 41755155)
24. Sospedra, M., and R. Martin. 2005. Antigen-specific therapies in multiple sclerosis. Int. Rev. Immunol. 24: 393-413.
25. Mannie, M. D., and D. J. Abbott. 2007. A fusion protein consisting of IL-16 and the encephalitogenic peptide of myelin basic protein constitutes an antigen-specific tolerogenic vaccine that inhibits experimental autoimmune encephalomyelitis. J. Immunol. 179: 1458-1465.
26. Mannie, M. D., B. A. Clayson, E. J. Buskirk, J. L. DeVine, J. J. Hernandez, and D. J. Abbott. 2007. IL-2/neuroantigen fusion proteins as antigen-specific tolerogens in experimental autoimmune encephalomyelitis (EAE): correlation of T cell-mediated antigen presentation and tolerance induction. J. Immunol. 178: 2835-2843.
27. Mannie, M. D., J. L. Devine, B. A. Clayson, L. T. Lewis, and D. J. Abbott. 2007. Cytokine-neuroantigen fusion proteins: new tools for modulation of myelin basic protein (MBP)-specific T cell responses in experimental autoimmune encephalomyelitis. J. Immunol. Methods 319: 118-132.
28. Blank, K., P. Lindner, B. Diefenbach, and A. Pluckthun. 2002. Self-immobilizing recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification. Protein Expression Purif. 24: 313-322. (Pubitemid 40047449)
29. - responders. Cell. Immunol. 212: 51-62.
30. Patel, D. M., P. Y. Arnold, G. A. White, J. P. Nardella, and M. D. Mannie. 1999. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J. Immunol. 163: 5201-5210.
31. + T cells: development of repression in vitro and modulation by APC-derived signals. Cell. Immunol. 230: 33-43.
32. Mannie, M. D., J. P. Nardella, G. A. White, P. Y. Arnold, and D. K. Davidian. 1998. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. Cell. Immunol. 186: 111-120.
33. Mannie, M. D., G. A. White, J. P. Nardella, D. K. Davidian, and P. Y. Arnold. 1998. Partial agonism elicits an enduring phase of T-cell-medicated antigen presentation. Cell. Immunol. 186: 83-93.
34. Gillis, S., and K. A. Smith. 1977. Long term culture of tumour-specific cytotoxic T cells. Nature 268: 154-156. (Pubitemid 8125246)
35. + T cells specific for myelin basic protein: IL-2 confers a prolonged postactivation refractory phase. Immunol. Cell Biol. 81: 8-19.
36. Ruuls, S. R., M. C. de Labie, K. S. Weber, C. A. Botman, R. J. Groenestein, C. D. Dijkstra, T. Olsson, and P. H. van der Meide. 1996. The length of treatment determines whether IFN-β prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats. J. Immunol. 157: 5721-5731.
37. van der Meide, P. H., M. C. de Labie, S. R. Ruuls, R. J. Groenestein, C. A. Botman, T. Olsson, and C. D. Dijkstra. 1998. Discontinuation of treatment with IFN-β leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats: rapid reversal of the antiproliferative activity of IFN-β and excessive expansion of autoreactive T cells as disease promoting mechanisms. J. Neuroimmunol. 84: 14-23.
38. Patel, D. M., R. W. Dudek, and M. D. Mannie. 2001. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes. Cell. Immunol. 214: 21-34.
39. Shinohara, M. L., J. H. Kim, V. A. Garcia, and H. Cantor. 2008. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29: 68-78.
40. Guo, B., E. Y. Chang, and G. Cheng. 2008. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118: 1680-1690. (Pubitemid 351632372)
41. + cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells. Mol. Immunol. 45: 4008-4019.
42. Martin-Saavedra, F. M., N. Flores, B. Dorado, C. Eguiluz, B. Bravo, A. Garcia-Merino, and S. Ballester. 2007. Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis. Mol. Immunol. 44: 3597-3607.
43. Mannie, M. D., P. Y. Paterson, D. C. U'Prichard, and G. Flouret. 1990. The N-and C-terminal boundaries of myelin basic protein determinants required for encephalitogenic and proliferative responses of Lewis rat T cells. J. Neuroimmunol. 26: 201-211.